Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 ...

Sanofi's Sarclisa SC formulation shows non-inferiority versus Sarclisa IV infusion in a late-stage study for treating ...

Strategically focused pipeline optimizes resource allocation to progress two product candidates with strongest clinical proof of concept: 4D-150 ...

Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of disease, ...

EU looks at India as best option over China, reflecting potential shifts in trade dynamics: Nandita Vijayasimha, Bengaluru Saturday, January 11, 2025, 08:00 Hrs [IST] The European ...

AEON Biopharma (NYSE: AEON) , a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar p ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...

Lingering inflation and market uncertainty are sending investors in search of defensive assets. Click here for top 5 ...

US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis: Spring House, Pennsylvania Saturday, January 11, 2025, 12:00 ...

Throughout ‘the year of the election’ – as 2024 was widely known – we were working with politicians and decision-makers to ...

The European pharma sector is on the brink of regulatory and operational updates with new papers from pharmaceutical ...